Zometa 4 mg Lyophilisat

Country: Շվեյցարիա

language: գերմաներեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

Säure zoledronicum

MAH:

Novartis Pharma Schweiz AG

ATC_code:

M05BA08

INN:

acid zoledronicum

pharmaceutical_form:

Lyophilisat

composition:

Praeparatio cryodesiccata: acidum zoledronicum 4.000 mg ut acidum zoledronicum monohydricum, mannitolum, natrii citras dihydricus corresp. natrium 6.41 mg, pro vitro. Solvens: aqua ad iniectabilia.

class:

B

therapeutic_group:

Synthetika

therapeutic_area:

Knochenmetastasen solider Tumoren und multiples Myelom, maligne Hypercalcämie

authorization_status:

zugelassen

authorization_date:

2000-11-28